You Won't Regret Reading the Facts on UnitedHealth.

Shares of UnitedHealth have moved -1.2% today, and are now trading at a price of $489.57. In contrast, the S&P 500 index saw a 0.4% change. Today's trading volume is 5,390,067 compared to the stock's average volume of 3,212,954.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. Based in Minnetonka, United States the company has 350,000 full time employees and a market cap of $457,429,254,144. UnitedHealth currently offers its equity investors a dividend that yields 1.3% per year.

The company is now trading -18.32% away from its average analyst target price of $599.39 per share. The 23 analysts following the stock have set target prices ranging from $530 to $650, and on average give UnitedHealth a rating of buy.

Over the last year, UNH shares have gone up 6.2%, which represents a difference of 18.8% when compared to the S&P 500. The stock's 52 week high is $558.1 per share whereas its 52 week low is $445.74. Based on UnitedHealth's relentless revenue and earnings growth, its core business remains strong and the stock price may maintain this level of performance.

2019-12-31 2020-12-31 2021-12-31
Revenue (MM) $240,269 $255,639 $285,273
Revenue Growth n/a 6.4% 11.59%
Gross Margins 23.2% 25.6% 23.6%
Gross Margins Growth n/a 10.34% -7.81%
Operating Margins 7.4% 8.2% 7.6%
Operating Margins Growth n/a 10.81% -7.32%
Earnings Per Share $14.33 $16.03 $18.08
EPS Growth n/a 11.86% 12.79%
Free Cash Flow (MM) $16,392 $20,123 $19,889
FCF Growth n/a 22.76% -1.16%
Capital Expenditures (MM) -$2,071 -$2,051 -$2,454
Net Debt / EBITDA 1.45 1.12 1.0
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.